NEW YORK (GenomeWeb News) – Metabolomics-based diagnostic firm Matrix-Bio today said it has signed an agreement with Quest Diagnostics covering the use of metabolomic biomarkers to develop a test for breast cancer recurrence.
Registering provides access to this and other free content.
Already have an account?Login Now.
Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.
Joel Achenbach explores at National Geographic why people find science difficult to believe.
In Science this week: gene linked to expansion of the human neocortex, and more.
The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.